» Articles » PMID: 4401306

Resistance of Noradrenaline in Blood Vessels to Depletion by 6-hydroxydopamine or Immunosympathectomy

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1972 Jan 1
PMID 4401306
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

1. The degree of the decrease in the noradrenaline concentrations caused by 6-hydroxydopamine or immunosympathectomy was different in different areas of the cardiovascular system.2. In rats or guinea-pigs 6-hydroxydopamine depleted the noradrenaline content of the heart by 90%, of the mesenteric vein by 80% and of the mesenteric artery and aorta by 30-60%. Immunosympathectomy elicited a 70% reduction in the cardiac noradrenaline but only a 50% reduction in the noradrenaline of the blood vessels of the rat.3. The tyrosine hydroxylase activity of the heart, blood vessels, or adrenal glands was not significantly altered 2 weeks after 6-hydroxydopamine. Nor was the monoamine oxidase activity in heart or blood vessels changed.4. The inconsistent ability of both 6-hydroxydopamine and immunosympathectomy to abolish experimental hypertension may be due to the partial persistence of noradrenaline and functional sympathetic nervous system activity in the blood vessels.

Citing Articles

Cardiovascular effects of the novel histamine H2 receptor agonist amthamine: interaction with the adrenergic system.

Coruzzi G, Gambarelli E, Bertaccini G, Timmerman H Naunyn Schmiedebergs Arch Pharmacol. 1996; 353(4):417-22.

PMID: 8935708 DOI: 10.1007/BF00261438.


Cardiovascular effects of selective agonists and antagonists of histamine H3 receptors in the anaesthetized rat.

Coruzzi G, Gambarelli E, Bertaccini G, Timmerman H Naunyn Schmiedebergs Arch Pharmacol. 1995; 351(6):569-75.

PMID: 7675114 DOI: 10.1007/BF00170155.


Monoamine oxidase in rat arteries: evidence for different forms and selective localization.

Coquil J, Goridis C, Mack G, Neff N Br J Pharmacol. 1973; 48(4):590-9.

PMID: 4788203 PMC: 1776159. DOI: 10.1111/j.1476-5381.1973.tb08245.x.


Rapid recovery of vascular adrenergic nerves in the rat after chemical sympathectomy with 6-hydroxydopamine.

Finch L, Haeusler G, Kuhn H, Thoenen H Br J Pharmacol. 1973; 48(1):59-72.

PMID: 4724194 PMC: 1776112. DOI: 10.1111/j.1476-5381.1973.tb08222.x.


The effects of an anti-atherosclerotic drug, pyridinolcarbamate, on heart, vascular and brain biogenic amines.

Berkowitz B, Hidaka H, Spector S Br J Pharmacol. 1973; 48(1):179-81.

PMID: 4724191 PMC: 1776097. DOI: 10.1111/j.1476-5381.1973.tb08239.x.


References
1.
Levi-Montalcini R, ANGELETTI P . Second symposium on catecholamines. Modification of sympathetic function. Immunosympathectomy. Pharmacol Rev. 1966; 18(1):619-28. View

2.
Varma D . Antihypertensive effect of methyldopa in metacorticoid immunosympathectomized rats. J Pharm Pharmacol. 1967; 19(1):61-2. DOI: 10.1111/j.2042-7158.1967.tb07998.x. View

3.
de la Lande I, Frewin D, Waterson J . The influence of sympathetic innervation on vascular sensitivity to noradrenaline. Br J Pharmacol Chemother. 1967; 31(1):82-93. PMC: 1557294. DOI: 10.1111/j.1476-5381.1967.tb01979.x. View

4.
Thoenen H, Tranzer J . Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1968; 261(3):271-88. DOI: 10.1007/BF00536990. View

5.
Thoenen H, Mueller R, Axelrod J . Increased tyrosine hydroxylase activity after drug-induced alteration of sympathetic transmission. Nature. 1969; 221(5187):1264. DOI: 10.1038/2211264a0. View